Editorial: a need for glucose monitoring on prokinetic treatment with a ghrelin agonist in diabetic gastroparesis?-Reference-Cited by-同舟云学术

Editorial: a need for glucose monitoring on prokinetic treatment with a ghrelin agonist in diabetic gastroparesis?

Published:2020-07-13 Issue:3 Volume:52 Page:545-546
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Hasler William L.¹^ORCID

Affiliation:

1. Division of Gastroenterology and Hepatology; University of Michigan Health System; Ann Arbor MI USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15792/fullpdf

Reference10 articles.

1. The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits;Ehrenpreis;Am J Gastroenterol,2013

2. Domperidone prescribing practices exposed patients to cardiac risk despite a “black box” warning: a Canadian tertiary care center study;Forbes;Can J Gastroenterol Hepatol,2016

3. Overall safety of relamorelin in adults with diabetic gastroparesis: analysis of phase 2a and 2b trial data;Camilleri;Aliment Pharmacol Ther,2020

4. Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients;Gonlachanvit;Dig Dis Sci,2003

5. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies;Janssens;N Engl J Med,1990

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: a need for glucose monitoring on prokinetic treatment with a ghrelin agonist in diabetic gastroparesis? Author's reply;Alimentary Pharmacology & Therapeutics;2020-07-13